atenolol has been researched along with Migraine Disorders in 16 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol has been most extensively studied and proved effective in 19 of 21 controlled trials." | 3.77 | [Beta-blockers and migraine]. ( Bousser, MG; Massiou, H, 1992) |
| "Trials of drugs in the prophylaxis of migraine have in general been unsatisfactory due to the difficulty in controlling many variables." | 3.75 | Beta-adrenoceptor blockade and migraine. ( Patel, L; Turner, P; Weerasuriya, K, 1982) |
| "To determine the minimum duration of migraine prophylaxis, after patients become pain-free." | 2.79 | Analysis of the duration of migraine prophylaxis. ( Almeida, KJ; Bernardino, SN; Silva-Néto, RP, 2014) |
| "Phenelzine was associated with a large decrease in the frequency and severity of migraine attacks." | 2.68 | Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression. ( Merikangas, JR; Merikangas, KR, 1995) |
| "The mean frequency of migraine days decreased from 10." | 1.36 | An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine. ( Jevoux, C; Krymchantowski, AV; Moreira, PF, 2010) |
| "The mean frequency of migraine days decreased from 10." | 1.35 | Quetiapine for the prevention of migraine refractory to the combination of atenolol + nortriptyline + flunarizine: an open pilot study. ( Jevoux, C; Krymchantowski, AV, 2008) |
| "Thalamic involvement in migraine is attractive given the complex and widespread nature of the sensory disturbance." | 1.33 | Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine? ( Goadsby, PJ; Shields, KG, 2005) |
| " Measures of dosing interval--used-on-schedule rate and therapeutic coverage--averaged between 44% and 71%." | 1.30 | Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better. ( Mulleners, WM; Steiner, TJ; Whitmarsh, TE, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silva-Néto, RP | 1 |
| Almeida, KJ | 1 |
| Bernardino, SN | 1 |
| Krymchantowski, AV | 2 |
| Jevoux, C | 2 |
| Moreira, PF | 1 |
| Shields, KG | 1 |
| Goadsby, PJ | 1 |
| Koch-Weser, J | 1 |
| Frishman, WH | 1 |
| Weerasuriya, K | 1 |
| Patel, L | 1 |
| Turner, P | 1 |
| Jackson, EA | 1 |
| Sullman, SA | 1 |
| Forssman, B | 1 |
| Lindblad, CJ | 1 |
| Zbornikova, V | 1 |
| Stensrud, P | 2 |
| Sjaastad, O | 2 |
| Merikangas, KR | 1 |
| Merikangas, JR | 1 |
| Mulleners, WM | 1 |
| Whitmarsh, TE | 1 |
| Steiner, TJ | 1 |
| Henry, P | 1 |
| Massiou, H | 1 |
| Bousser, MG | 1 |
| Kumar, KL | 1 |
| Cooney, TG | 1 |
| Johannsson, V | 1 |
| Nilsson, LR | 1 |
| Widelius, T | 1 |
| Jäverfalk, T | 1 |
| Hellman, P | 1 |
| Akesson, JA | 1 |
| Olerud, B | 1 |
| Gustafsson, CL | 1 |
| Raak, A | 1 |
| Sandahl, G | 1 |
4 reviews available for atenolol and Migraine Disorders
| Article | Year |
|---|---|
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Me | 1981 |
Beta-adrenoceptor blockade and migraine.
Topics: Adrenergic beta-Antagonists; Atenolol; Brain; Clinical Trials as Topic; Double-Blind Method; Humans; | 1982 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; | 1984 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Pote | 1992 |
8 trials available for atenolol and Migraine Disorders
| Article | Year |
|---|---|
Analysis of the duration of migraine prophylaxis.
Topics: Adolescent; Adult; Atenolol; Dose-Response Relationship, Drug; Female; Flunarizine; Humans; Internat | 2014 |
Beta-adrenoceptor blockade and migraine.
Topics: Adrenergic beta-Antagonists; Atenolol; Brain; Clinical Trials as Topic; Double-Blind Method; Humans; | 1982 |
Atenolol for migraine prophylaxis.
Topics: Adolescent; Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Mi | 1983 |
Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; M | 1980 |
Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; M | 1980 |
Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
Topics: Adrenergic beta-Antagonists; Adult; Anxiety; Atenolol; Blood Pressure; Depressive Disorder; Disabili | 1995 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Pote | 1992 |
Atenolol in migraine prophylaxis a double-blind cross-over multicentre study.
Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; M | 1987 |
6 other studies available for atenolol and Migraine Disorders
| Article | Year |
|---|---|
Quetiapine for the prevention of migraine refractory to the combination of atenolol + nortriptyline + flunarizine: an open pilot study.
Topics: Adult; Antipsychotic Agents; Atenolol; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combinatio | 2008 |
An open pilot study assessing the benefits of quetiapine for the prevention of migraine refractory to the combination of atenolol, nortriptyline, and flunarizine.
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Atenolol | 2010 |
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Electric Stimulation; Glut | 2005 |
Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Atenolol; Dose-Response Rel | 1998 |
[Migraine: a disease, not a symptom].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analgesics; Analgesics, Non-Narcotic; Ant | 2002 |
Visual symptoms after atenolol therapy for migraine.
Topics: Adult; Atenolol; Female; Humans; Migraine Disorders; Vision Disorders | 1990 |